Trial intelligence / Profile preview

Breast Reconstruction with Adipose-derived Mesenchymal Stem Cells After Breast-conserving Surgery

jRCT1090220159Completed

Sponsor
Rie Yamashita
Start
Jan 2014
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Open-label, single-arm trial of adipose derived mesenchymal stromal cells in Tuberous Breast Deformity and breast cancer, sponsored by Rie Yamashita. Primary endpoint: Primary volumetric outcome. Started Jan 2014; status: completed.

02

Drugs

adipose derived mesenchymal stromal cells
03

Conditions

Tuberous Breast Deformitybreast cancer

Beyond the preview

Go deeper on jRCT1090220159.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1090220159.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call